Bone Biologics (NASDAQ:BBLG) reported quarterly losses of $(0.17) per share. This is a 21.43 percent decrease over losses of $(0.14) per share from the same period last year.
Tudor Pickering Initiates Coverage On Tesla with Sell Rating, Announces Price Target of $537
Tudor Pickering initiates coverage on Tesla (NASDAQ:TSLA) with a Sell rating and announces Price Target of $537.